Form 8-K - Current report:
SEC Accession No. 0001104659-24-077596
Filing Date
2024-07-03
Accepted
2024-07-03 08:55:12
Documents
14
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418844d1_8k.htm   iXBRL 8-K 44392
2 EXHIBIT 1.1 tm2418844d1_ex1-1.htm EX-1.1 123520
  Complete submission text file 0001104659-24-077596.txt   372306

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20240627.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20240627_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20240627_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2418844d1_8k_htm.xml XML 3565
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 241098318
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)